Lamistar 150 mg/30 mg Tablet

By Lamistar

Rx

30 Tablet in a Strip

Composition icon

Composition

Lamivudine(150mg) + Stavudine(30mg)

Manufacturer - Hetero Drugs Ltd icon

Manufacturer - Hetero Drugs Ltd

7-2-A2, Hetero Corporate, Industrial Estates, Sanath Nagar, Hyderabad – 500 018. Telangana, INDIA

Expires on or after icon

Expires on or after

September, 2025

About Lamistar 150 mg/30 mg Tablet

Lamistar 150 mg/30 mg Tablet is a combination of two antiretrovirals used in the treatment of HIV (human immunodeficiency virus) infection. HIV weakens the immune system, making the body vulnerable to infections and illnesses, eventually leading to AIDS (acquired immunodeficiency syndrome). By boosting immunity and controlling the growth of HIV in the body, Lamistar 150 mg/30 mg Tablet helps manage and treat AIDS, thereby improving the individual's quality of life and prolonging lifespan.

It is crucial to take Lamistar 150 mg/30 mg Tablet on an empty stomach for optimal effectiveness. Consistency in taking the medication at the same time every day enhances its efficacy. Missing a dose can impact your recovery, so it is important to adhere to the prescribed regimen without fail. Completing the full course of treatment as instructed by your doctor is essential for successful management of HIV infection.

While using Lamistar 150 mg/30 mg Tablet, some individuals may experience common side effects such as nausea, headache, tiredness, diarrhea, and dry mouth. These side effects are usually temporary and tend to resolve on their own; however, if they persist or worsen, it is advisable to seek medical advice. Before initiating treatment, it is essential to consult your healthcare provider, especially if you are pregnant, breastfeeding, or have any underlying health conditions. Your doctor may recommend regular laboratory tests to monitor your blood counts and overall health status.

Lamistar 150 mg/30 mg Tablet is a prescription medication that should be used as directed by your doctor. It contains Lamivudine and Stavudine, which are nucleoside reverse transcriptase inhibitors that impede the replication of the virus by interfering with specific enzymes necessary for its reproduction. Avoid consuming alcohol while on Lamistar 150 mg/30 mg Tablet, as it may heighten the risk of side effects. Effective birth control methods should be discussed with your doctor to prevent pregnancy during treatment. It is important to note that breastfeeding is not recommended for individuals infected with HIV or taking Lamistar 150 mg/30 mg Tablet. This medication is also not recommended for use in children.


Benefits

Lamistar 150 mg/30 mg Tablet offers significant benefits for individuals with HIV infection. By inhibiting the multiplication of the HIV virus in the body, this medication plays a crucial role in managing the infection and enhancing the overall functionality of the immune system. This, in turn, can reduce the likelihood of developing complications such as new infections and ultimately improve the quality of life for the individual. It is important to note that Lamistar 150 mg/30 mg Tablet is not a cure for HIV or AIDS, nor should it be used to prevent HIV after accidental exposure to a risk.

For optimal results, it is essential to adhere strictly to the prescribed dosage provided by your healthcare provider. By following the recommended regimen diligently, including taking all doses as directed and at the specified times, you can maximize the effectiveness of the treatment. Consistent adherence to the medication schedule also helps to minimize the risk of the HIV infection becoming resistant to antiretroviral drugs, thereby ensuring the continued efficacy of the treatment.

While Lamistar 150 mg/30 mg Tablet offers these significant benefits in managing HIV infection, it is important to recognize that it does not prevent the transmission of HIV to others. Therefore, maintaining open and honest communication with healthcare providers and practicing safe behaviors remain critical in preventing the spread of the virus to other individuals. By leveraging the benefits of Lamistar 150 mg/30 mg Tablet alongside responsible personal behaviors, individuals can experience improved health outcomes and a better quality of life in their journey managing HIV infection.


How to use the Lamistar 150 mg/30 mg Tablet

To use Lamistar 150 mg/30 mg Tablet effectively, follow the dosage instructions provided by your doctor. It is important to swallow the tablet whole without chewing, crushing, or breaking it. Remember to take Lamistar 150 mg/30 mg Tablet on an empty stomach. Following these guidelines will help ensure that you receive the full benefits of the medication. Always consult your doctor for the correct dosage and duration of treatment tailored to your specific needs.


Uses of Lamistar 150 mg/30 mg Tablet

The Lamistar 150 mg/30 mg Tablet is typically used in the treatment of HIV infection. This medication is prescribed to individuals diagnosed with HIV to help manage the condition and its symptoms. By taking Lamostad Tablets as directed by a healthcare professional, patients can effectively control the progression of the HIV infection. It is important to follow the prescribed dosage and guidelines for the best results in managing this medical condition.


What conditions Lamistar 150 mg/30 mg Tablet treats?

Lamistar 150 mg/30 mg Tablet is prescribed to treat HIV (human immunodeficiency virus) infection by boosting immunity to fight against HIV and manage or treat AIDS (acquired immunodeficiency syndrome). It restricts HIV growth in the body, reduces related complications, and can improve lifespan. Taking it on an empty stomach, regularly at the same time, and completing the full treatment course is crucial. Common side effects include nausea, headache, tiredness, diarrhea, and dry mouth. Consult your doctor for persistent or serious side effects. Regular lab tests may be advised. Avoid breastfeeding or sharing personal items if HIV positive.


Should you consult a doctor?

Seek medical attention if you experience persistent side effects such as nausea, headache, tiredness, diarrhea, dry mouth, or any severe symptoms while taking Lamistar 150 mg/30 mg Tablet. It is crucial to inform your doctor if side effects worsen or do not improve over time. Additionally, consult your healthcare provider before starting the treatment if you are pregnant, breastfeeding, or have any underlying health conditions. Regularly scheduled laboratory tests may be recommended by your doctor to monitor your health status during the treatment. If you are living with HIV, it is essential to avoid breastfeeding and sharing personal items like razors or toothbrushes. Consult your healthcare provider for guidance on safe sex practices to prevent the transmission of HIV. Missing a dose of Lamistar 150 mg/30 mg Tablet can impact your recovery, so adhere to the prescribed dosage schedule. Completing the full course of treatment as advised by your doctor is essential for successful management of HIV infection.


Side effects of Lamistar 150 mg/30 mg Tablet

When taking Lamistar 150 mg/30 mg Tablet, some common side effects may occur. These side effects usually go away on their own as your body gets used to the medication. However, it is important to consult your doctor if they persist or if you are concerned about them. These side effects may include headache, nausea, diarrhea, peripheral neuropathy (characterized by tingling and numbness in the feet and hands), rash, and vomiting. Keep a note of any unusual symptoms and discuss them with your healthcare provider for proper guidance.


Safety advice

scroll

liver

When it comes to using Lamistar 150 mg/30 mg Tablet, it is deemed generally safe for individuals with liver disease based on the limited data we have. There is no definitive need for adjusting the dosage of Lamistar 150 mg/30 mg Tablet in patients with liver issues. However, it is crucial to consult your doctor before starting this medication. If you experience any signs or symptoms of jaundice while on Lamistar 150 mg/30 mg Tablet, it is important to notify your doctor promptly, as discontinuation of the medicine may be necessary.

scroll

kidney

Lamistar 150 mg/30 mg Tablet requires caution in patients with kidney disease. Dosage adjustment might be necessary. It is advised to consult a doctor before use.

scroll

alcohol

When taking Lamistar 150 mg/30 mg Tablet, be cautious when drinking alcohol. It is recommended to consult your doctor regarding alcohol consumption.

scroll

driving

When taking Lamistar 150 mg/30 mg Tablet, be cautious when driving as it can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

scroll

pregnancy

Lamistar 150 mg/30 mg Tablet may be unsafe during pregnancy. Animal studies show harm to the baby. Consult your doctor for guidance on benefits versus risks.

scroll

breastfeeding

Lamistar 150 mg/30 mg Tablet is likely safe to use while breastfeeding. Human data indicates no significant risk to the baby.


Consumption warning before consuming Lamistar 150 mg/30 mg Tablet

Before consuming Lamistar 150 mg/30 mg Tablet, it is crucial to follow important guidelines for your safety and best results. This medication is a combination of antiretrovirals used to treat HIV infection. It enhances your immunity to combat the virus and manage AIDS. To maximize effectiveness, take Lamistar 150 mg/30 mg Tablet on an empty stomach at the same time every day without missing a dose. Completing the full course is essential unless your doctor advises otherwise. Common side effects like nausea, headache, and fatigue are usually temporary, but notify your doctor if they persist. Before starting treatment, consult your doctor if pregnant, breastfeeding, or with any health condition. Regular medical tests may be required to monitor your health. If HIV positive, refrain from breastfeeding and avoid sharing personal items. Discuss safe sex practices with your doctor to prevent HIV transmission.


What if you forgot to take Lamistar 150 mg/30 mg Tablet?

If you forget to take a dose of Lamistar 150 mg/30 mg Tablet, try to take it as soon as you remember. But, if it's near the time for your next dose, then just skip the missed dose and resume your normal dosing schedule. Remember not to take a double dose to make up for the missed one.


Related lab tests

For individuals taking Lamistar 150 mg/30 mg Tablet, it is important to monitor their HIV status regularly. The following lab tests are recommended to check for HIV infection:

1. HIV 1 & 2, Ab Western Blot: This test is used to confirm the presence of antibodies to both HIV-1 and HIV-2 in the blood.

2. HIV 1 And 2 Antibody - Chromatography: This test detects antibodies to both HIV-1 and HIV-2 using chromatography techniques.

3. HIV 1 And 2 Antibody - ELISA: This test screens for antibodies to HIV-1 and HIV-2 using Enzyme-Linked Immunosorbent Assay (ELISA) method.

Regular monitoring with these lab tests can help ensure early detection and management of HIV infection in individuals using Lamistar 150 mg/30 mg Tablet.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic Class-
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

316.7

Inclusive of all taxes

Content verified by

chevron-right

Dr. Mansi Chaudhari

MBBS - General Medicine

Last update on 11-Feb-2025